Pseudoginsenoside Rh2

• Description :

  Pseudoginsenoside Rh2, synthesized from Ginsenoside Rh2, possesses anti-cancer activitied[1].

• CAS Number :

  [1370264-16-6]

• UNSPSC :

  12352005

• Target :

  Drug Derivative

• Type :

  Reference compound

• Related Pathways :

  Others

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/pseudoginsenoside-rh2.html

• Solubility :

  10 mM in DMSO

• Smiles :

  C[C@]12[C@@](C[C@H]([C@@]3([H])[C@]2(CC[C@@H]3/C(C)=C/CCC(C)(O)C)C)O)([H])[C@@]4([C@@](C(C)([C@H](CC4)O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)CO)C)([H])CC1)C

• Molecular Formula :

  C36H62O8

• Molecular Weight :

  622.87

• References & Citations :

  [1]Qian G, et al. Synthesis and anti-cancer cell activity of pseudo-ginsenoside Rh2. Steroids. 2014 Dec;92:1-6.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported